Influence of unbalanced opioid policy on pain management and home-based palliative care services in Republic of Georgia
Main Article Content
Abstract
Introduction: Most patients with incurable diseases prefer to spend their treasured time in home settings. As pain is the most frequent symptom, often requiring opioid analgesics, it is essential that outpatient medical services are supported by policies that allow managing patients’ conditions at home. This paper aims to show how over-restrictive regulations/policies can impact patients’ ability to access pain management and hamper the development of home-based palliative care services.
Methods: To evaluate the influence of strict regulations on pain management and their impact on home-based palliative care services, on one hand the opioid legislation and policy documents were reviewed and on the other opioid consumption reports, data on mortality and provided palliative care services, and data from the patient survey were analyzed.
Results: The palliative care program states that only incurable patients who are at the end of their lives and need home-based support can benefit from the program. Additionally, the physician must be convinced that the diagnosis is correct and that the estimated life expectancy is no more than 3-6 months (duration of benefiting from the program). Consequently, fearing the penalties, physicians mostly include patients in the program, when apparent signs of death are present. Therefore, patients have to be hospitalized, to receive care. As a result, the number of provided home based services has decreased more than half and its’ ratio to inpatient services is 1:4.
Simultaneously, the legislation allows prescribing opioids only to terminally ill patients, for whom no other treatment options are available. Before being prescribed morphine, about 94% of the terminal patients experienced moderate to severe pain. 75% experienced severe pain for 1 month and more. Yet, opioids were prescribed with substantial delay in most cases (61-70%). In 45%, morphine was first prescribed by palliative care physicians available only at inpatient units.
Conclusion: Strict opioid policies negatively impact pain management in palliative care patients. Even been incurable, most patients cannot receive appropriate pain treatment, until they reach the “end-of-life” stage, or receive such treatment in inpatient settings. Such an approach ignores the possibility of improving the quality of life for patients in their home setting.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Higginson IJ, Sen-Gupta GJA. Place of Care in Advanced Cancer: A Qualitative Systematic Literature Review of Patient Preferences. https://home.liebertpub.com/jpm. 2005;3(3):287-300. doi:10.1089/JPM.2000.3.287
3. WHO, WPCA. Global Atlas of Palliative Care at the End of Life.; 2014. Accessed August 3, 2018. www.ehospice.com
4. World Health Organization. Strengthening of Palliative Care as a Component of Integrated Treatment throughout the Life Course. J Pain Palliat Care Pharmacother. 2014;28(2):130-134.
doi:10.3109/15360288.2014.911801
5. Palliative care. Accessed May 6, 2025. https://www.who.int/news-room/fact-sheets/detail/palliative-care
6. WHO. Astana Declaration. Published 2018. Accessed July 29, 2020.
https://www.who.int/primary-health/conference-phc/declaration
7. WHO. National cancer control programmes : policies and managerial guidelines. Published 2002. Accessed March 21, 2025. https://iris.who.int/handle/10665/42494
8. WHO. Integrating Palliative Care and Symptom Relief into Primary Health Care.; 2018. Accessed November 3, 2018. http://www.who.int/servicedeliverysafety/en
9. Gomes B, Calanzani N, Curiale V, Mccrone P, Higginson IJ. Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev. 2013;2016(3). doi:10.1002/14651858.CD007760.PUB2
10. Maresova P, Hruška J, Randlova K, Rezny L, Carrillo-de-la-Peña MT, Kuca K. Systematic Review of the Cost-Effectiveness of Home-Based Palliative Care Interventions in Patients with Cancer: A Critical Analysis. Cancer Manag Res. 2024;16:1155-1174. doi:10.2147/CMAR.S472649
11. Stjernswärd J, Foley KM, Ferris FD. The Public Health Strategy for Palliative Care. J Pain Symptom Manage. 2007;33(5):486-493. doi:10.1016/j.jpainsymman.2007.02.016
12. International Narcotics Control Board (INCB). Narcotic Drugs — Estimated World Requirements for 2024 — Statistics for 2022. Published online 2023. Accessed March 21, 2025. www.incb.org
13. Kiknadze N, Dzotsenidze P. Palliative Care Development in Georgia. J Pain Symptom Manage. 2018;55:S25-S29. doi:10.1016/j.jpainsymman.2017.03.021
14. Deaths - National Statistics Office of Georgia. Accessed April 15, 2025.
https://www.geostat.ge/en/modules/categories/320/deaths
15. ძოწენიძე ფატი, რუხაძე თამარი, აბესაძე იოსებ. “ქრონიკული ტკივილის მართვის.”; 2012. Accessed July 30, 2018. http://www.moh.gov.ge/uploads/guidelines/2017/06/02/9bdedb3c90dcec579e7f9a0f589eafaf.pdf
16. Pati Dzotsenidze T. ქრონიკული ტკივილის მართვაში არსებული ბარიერების შეფასება და მათი ზემოქმედება სამედიცინო მომსახურების ხარისხზე. ივანე ჯავახიშვილის სახელობის თბილისის სახელმწიფო უნივერსიტეტი.; 2019.
17. Cherny NI, Baselga J, de Conno F, Radbruch L. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol. 2010;21(3):615-626. doi:10.1093/annonc/mdp581
18. Cherny NI, Catane R, Kosmidis PA. Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering. Ann Oncol. 2006;17(6):885-887. doi:10.1093/annonc/mdl073
19. Cherny NI, Cleary J, Scholten W, Radbruch L, Torode J. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol. 2013;24(SUPPLEMENT11): xi7-xi13. doi:10.1093/ANNONC/MDT498
20. International Narcotics control Board. Technical Reports. Narcotic Drugs - Technical Report. Published 2021. Accessed October 7, 2022. https://www.incb.org/incb/en/narcotic-drugs/Technical_Reports/narcotic_drugs_reports.html
21. UN, INCB. 2010 INTERNATIONAL NARCOTICS CONTROL BOARD Ensuring Adequate Access for Medical and Scientific Purposes UNITED NATIONS.; 2010. Accessed July 31, 2018. www.incb.org
22. Aaron Gilson, David Joranson, Karen Ryan, Jody Garthwaite JK. Achieving Balance In State Pain Policy, A Progress Report Card.; 2006. doi:10.1097/01.JTN.0000315778.97341.9a
23. PPSG APMG. Drug Control and Access to Medicines (DCAM).; 2009. Accessed July 30, 2018. http://apmglobalhealth.com/sites/apmglobalhealth.com/files/projects/docs/compendium.pdf
24. Connor SR. The global atlas of palliative care at the end of life: An advocacy tool. Eur J Palliat Care. Published online 2014. doi:10.1159/000440690
25. Worldwide Palliative Care Alliance. Accessed April 27, 2025.
https://repository.gheli.harvard.edu/repository/11295/
26. ნარკოტიკული ანალგეტიკებით სიმპტომურ მკურნალობაზე მყოფი კონტინგენტის საჭიროებისათვის ნარკოტიკული საშუალებების შენახვის, აღრიცხვის, დანიშვნის, გამოწერის, გაცემისა და გამოყენების დროებითი წესების დამტკიცების შესახებ | სსიპ ”საქართველოს საკანონმდებლო მაცნე”. Accessed April 22, 2021. https://matsne.gov.ge/ka/document/view/1065520?publication=0
27. ბრძანება32-102სშჯსსს, შსს2000. Joint Decree of MLHSA an MIA 32-102.pdf.
28. Dzotsenidze P, Abesadze I, Maurer MA, et al. Identifying barriers and contradictions in laws affecting pain management in Georgia. Transl Clin Med - Georg Med J. 2018;3(2):19-30. doi:10.29088/TCM-GMJ.2018-2.19
29. Dzotsenidze P, Lekashvili T, Chikhladze N, Jorbenadze M, Abesadze I, Kordzaia D. Impact of Ambiguous and Restrictive Regulations on Opioid-Prescribing Practice in Georgia. J Pain Symptom Manage. Published online March 2018. doi:10.1016/j.jpainsymman.2018.03.018
30. Cherny NI, Baselga J, de Conno F, Radbruch L. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: A report from the ESMO/EAPC opioid policy initiative. Ann Oncol. Published online 2010. doi:10.1093/annonc/mdp581
31. SHAVDIA N, DZOTSENIDZE P, SHAVDIA N. CANCER PAIN AND ITS MANAGEMENT WITH OPIOIDS IN GEORGIA. Exp Clin Med Georg. 2022;(8). doi:10.52340/JECM.2022.08.17
32. OSGF. Assessment of Palliative Care Services - სამოქალაქო საზოგადოების ფონდი. Published 2021. Accessed March 22, 2025. https://csf.ge/en/assessment-of-palliative-care-services/
33. Global Data Platform to Calculate SHS and Palliative Care Need - IAHPC. Accessed March 22, 2025. https://iahpc.org/research/global-data-platform-to-calculate-shs-and-palliative-care-need/database/
34. Marie Knaul F, Farmer PE, Krakauer EL, et al. The Lancet Commissions Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018;391:1391-1454. doi:10.1016/S0140-6736(17)32513-8
35. Anekar AA, Hendrix JM, Cascella M. WHO Analgesic Ladder. J R Coll Physicians Edinb. 2023; 38(3):284. doi:10.1007/978-3-642-28753-4_102537
36. WHO, 1986. Cancer Pain Relief. Accessed July 29, 2018.
http://apps.who.int/iris/bitstream/handle/10665/43944/9241561009_eng.pdf